|
1
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Song Y, Li L, Ou Y, Gao Z, Li E, Li X,
Zhang W, Wang J, Xu L, Zhou Y, et al: Identification of genomic
alterations in oesophageal squamous cell cancer. Nature. 509:91–95.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Visvader JE and Lindeman GJ: Cancer stem
cells in solid tumours: Accumulating evidence and unresolved
questions. Nat Rev Cancer. 8:755–768. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Singh SK, Clarke ID, Terasaki M, Bonn VE,
Hawkins C, Squire J and Dirks PB: Identification of a cancer stem
cell in human brain tumors. Cancer Res. 63:5821–5828.
2003.PubMed/NCBI
|
|
5
|
Ponti D, Costa A, Zaffaroni N, Pratesi G,
Petrangolini G, Coradini D, Pilotti S, Pierotti MA and Daidone MG:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patrawala L, Calhoun T,
Schneider-Broussard R, Li H, Bhatia B, Tang S, Reilly JG, Chandra
D, Zhou J, Claypool K, et al: Highly purified CD44+
prostate cancer cells from xenograft human tumors are enriched in
tumorigenic and metastatic progenitor cells. Oncogene.
25:1696–1708. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ricci-Vitiani L, Lombardi DG, Pilozzi E,
Biffoni M, Todaro M, Peschle C and De Maria R: Identification and
expansion of human colon-cancer-initiating cells. Nature.
445:111–115. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li C, Heidt DG, Dalerba P, Burant CF,
Zhang L, Adsay V, Wicha M, Clarke MF and Simeone DM: Identification
of pancreatic cancer stem cells. Cancer Res. 67:1030–1037. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eramo A, Lotti F, Sette G, Pilozzi E,
Biffoni M, Di Virgilio A, Conticello C, Ruco L, Peschle C and De
Maria R: Identification and expansion of the tumorigenic lung
cancer stem cell population. Cell Death Differ. 15:504–514. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang KH, Dai YD, Tong M, Chan YP, Kwan PS,
Fu L, Qin YR, Tsao SW, Lung HL, Lung ML, et al: A CD90+
tumor-initiating cell population with an aggressive signature and
metastatic capacity in esophageal cancer. Cancer Res. 73:2322–2332.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li S, Yue D, Chen X, Wang L, Li J, Ping Y,
Gao Q, Wang D, Zhang T, Li F, et al: Epigenetic regulation of
CD271, a potential cancer stem cell marker associated with
chemoresistance and metastatic capacity. Oncol Rep. 33:425–432.
2015.PubMed/NCBI
|
|
12
|
Huang SD, Yuan Y, Liu XH, Gong DJ, Bai CG,
Wang F, Luo JH and Xu ZY: Self-renewal and chemotherapy resistance
of p75NTR positive cells in esophageal squamous cell
carcinomas. BMC Cancer. 9:92009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Okano H, Kawahara H, Toriya M, Nakao K,
Shibata S and Imai T: Function of RNA-binding protein Musashi-1 in
stem cells. Exp Cell Res. 306:349–356. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hadziselimovic N, Vukojevic V, Peter F,
Milnik A, Fastenrath M, Fenyves BG, Hieber P, Demougin P, Vogler C,
de Quervain DJ, et al: Forgetting is regulated via Musashi-mediated
translational control of the Arp2/3 complex. Cell. 156:1153–1166.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang XY, Yu H, Linnoila RI, Li L, Li D, Mo
B, Okano H, Penalva LO and Glazer RI: Musashi1 as a potential
therapeutic target and diagnostic marker for lung cancer.
Oncotarget. 4:739–750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Simon E, Petke D, Böger C, Behrens HM,
Warneke V, Ebert M and Röcken C: The spatial distribution of
LGR5+ cells correlates with gastric cancer progression.
PLoS One. 7:e354862012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rezza A, Skah S, Roche C, Nadjar J,
Samarut J and Plateroti M: The overexpression of the putative gut
stem cell marker Musashi-1 induces tumorigenesis through Wnt and
Notch activation. J Cell Sci. 123:3256–3265. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li N, Yousefi M, Nakauka-Ddamba A, Li F,
Vandivier L, Parada K, Woo DH, Wang S, Naqvi AS, Rao S, et al: The
Msi family of RNA-binding proteins function redundantly as
intestinal oncoproteins. Cell Reports. 13:2440–2455. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Götte M, Greve B, Kelsch R, Müller-Uthoff
H, Weiss K, Masouleh B Kharabi, Sibrowski W, Kiesel L and Buchweitz
O: The adult stem cell marker Musashi-1 modulates endometrial
carcinoma cell cycle progression and apoptosis via Notch-1 and
p21WAF1/CIP1. Int J Cancer. 129:2042–2049. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang XY, Penalva LO, Yuan H, Linnoila RI,
Lu J, Okano H and Glazer RI: Musashi1 regulates breast tumor cell
proliferation and is a prognostic indicator of poor survival. Mol
Cancer. 9:2212010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu DC, Yang ZL and Jiang S:
Identification of musashi-1 and ALDH1 as carcinogenesis,
progression, and poor-prognosis related biomarkers for gallbladder
adenocarcinoma. Cancer Biomark. 8:113–121. 2010.2011. View Article : Google Scholar
|
|
22
|
Hou T, Zhang W, Tong C, Kazobinka G, Huang
X, Huang Y and Zhang Y: Putative stem cell markers in cervical
squamous cell carcinoma are correlated with poor clinical outcome.
BMC Cancer. 15:7852015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Fox RG, Lytle NK, Jaquish DV, Park FD, Ito
T, Bajaj J, Koechlein CS, Zimdahl B, Yano M, Kopp JL, et al:
Image-based detection and targeting of therapy resistance in
pancreatic adenocarcinoma. Nature. 534:407–411. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen HY, Lin LT, Wang ML, Lee SH, Tsai ML,
Tsai CC, Liu WH, Chen TC, Yang YP, Lee YY, et al: Musashi-1
regulates AKT-derived IL-6 autocrinal/paracrinal malignancy and
chemoresistance in glioblastoma. Oncotarget. 7:42485–42501. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Moghbeli M, Rad A, Farshchian M,
Taghehchian N, Gholamin M and Abbaszadegan MR: Correlation between
Meis1 and Msi1 in esophageal squamous cell carcinoma. J
Gastrointest Cancer. 47:273–277. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McDonald JW and Pilgram TK: Nuclear
expression of p53, p21 and cyclin D1 is increased in
bronchioloalveolar carcinoma. Histopathology. 34:439–446. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xue LY, Hu N, Song YM, Zou SM, Shou JZ,
Qian LX, Ren LQ, Lin DM, Tong T, He ZG, et al: Tissue microarray
analysis reveals a tight correlation between protein expression
pattern and progression of esophageal squamous cell carcinoma. BMC
Cancer. 6:2962006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Langan RC, Mullinax JE, Ray S, Raiji MT,
Schaub N, Xin HW, Koizumi T, Steinberg SM, Anderson A, Wiegand G,
et al: A pilot study assessing the potential role of non-CD133
colorectal cancer stem cells as biomarkers. J Cancer. 3:231–240.
2012. View
Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pastò A, Serafin V, Pilotto G, Lago C,
Bellio C, Trusolino L, Bertotti A, Hoey T, Plateroti M, Esposito G,
et al: NOTCH3 signaling regulates MUSASHI-1 expression in
metastatic colorectal cancer cells. Cancer Res. 74:2106–2118. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu X, Yang WT and Zheng PS: Msi1 promotes
tumor growth and cell proliferation by targeting cell cycle
checkpoint proteins p21, p27 and p53 in cervical carcinomas.
Oncotarget. 5:10870–10885. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Moghbeli M, Forghanifard MM, Sadrizadeh A,
Mozaffari HM, Golmakani E and Abbaszadegan MR: Role of Msi1 and
MAML1 in regulation of Notch signaling pathway in patients with
esophageal squamous cell carcinoma. J Gastrointest Cancer.
46:365–369. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Moghbeli M, Sadrizadeh A, Forghanifard MM,
Mozaffari HM, Golmakani E and Abbaszadegan MR: Role of Msi1 and
PYGO2 in esophageal squamous cell carcinoma depth of invasion. J
Cell Commun Signal. 10:49–53. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kuang RG, Kuang Y, Luo QF, Zhou CJ, Ji R
and Wang JW: Expression and significance of Musashi-1 in gastric
cancer and precancerous lesions. World J Gastroenterol.
19:6637–6644. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ying M, Wang S, Sang Y, Sun P, Lal B,
Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J and
Xia S: Regulation of glioblastoma stem cells by retinoic acid: Role
for Notch pathway inhibition. Oncogene. 30:3454–3467. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu F, Shi Y, Wang J, Li J, Fan D and Ai W:
Deficiency of Kruppel-like factor KLF4 in mammary tumor cells
inhibits tumor growth and pulmonary metastasis and is accompanied
by compromised recruitment of myeloid-derived suppressor cells. Int
J Cancer. 133:2872–2883. 2013.PubMed/NCBI
|
